Searchable abstracts of presentations at key conferences in endocrinology

ea0040p18 | (1) | ESEBEC2016

Massive bilateral pheocromocitomas: a rare case

Martins D , Baptista C , Rodrigues D , Miguel Melo , Cardoso L M , Vicente N , Oliveira D , Ventura M , Lages A , Carrilho F

Introduction: Pheochromocytoma is a rare catecholamine-secreting tumor that arises from the chromaffin tissue of the adrenal medulla. Of the reported cases, only 10% consist in bilateral lesions and the probability of multiple endocrine neoplasia should always be investigated.Clinical case: Female patient, 19 years old, presented with a clinical history with 2 years of evolution, characterized by episodes of palpitations, headache, nausea and abdominal d...

ea0031p43 | Clinical biochemistry | SFEBES2013

High pulmonary artery pressure is associated with BNP and NT-proBNP in lowlanders acclimatising to high altitude

Mellor A , Hill N E , Boos C , Holdsworth D , Begley J , Stacey M , Hall D , Lumley A , Hawkins A , Foxen S , Hara J O' , Smith C , Ball S , Woods D

Background: We have previously demonstrated that the natriuretic peptides BNP and NT-proBNP rise with ascent to high altitude (HA). Both peptides are classically markers of congestive cardiac failure but have also recently been found to be associated with pulmonary hypertension at sea-level (SL). As pulmonary hypertension is central to the risk of high altitude pulmonary oedema we aimed to establish if there was any association between high pulmonary artery systolic pressure (...

ea0011p907 | Thyroid | ECE2006

Comparison of cytogenetic damage in patients with differentiated thyroid cancer receiving ablative 131I therapy in the hypothyroid status versus the euthyroid status (rhTSH assisted treatment)

Frigo A , Francia G , Davi MV , Boni G , Traino C , Scilanga L , Bernardi F , Mariani G , Vaiano A , Colato C , Lo Cascio V , Ferdeghini M

The long-term risk of carcinogenic and genetic damage following the treatment with 131I for differentiated thyroid cancer (DTC) is quite low. The hypothyroid status (HS), at the time of 131I administration, decreases the renal clearance of 131I and increases the whole-body, blood and bone marrow irradiation, unlike the euthyroid status (ES). Chromosome aberrations (CA) in peripheral lymphocytes reflect blood cells exposure to irradiation. This ...

ea0090ep194 | Calcium and Bone | ECE2023

Completely intra-thyroidal parathyroid adenoma: A rare entity

Baruah Manash , Roy Bubul C , Baruah Upasana M , Das Anup K , Bhuyan Ashok K , Patawari Pankaj

Introduction: Intra thyroidal parathyroid adenoma is an uncommon presentation of primary hyperparathyroidism (PHPT). Herein we report such a patient who had recurrent hypercalcemia after a classical parathyroid exploration.Case presentation: 45 year old female, home-maker had a long standing history of weakness, back and lower limb pain, loss of appetite. Preliminary evaluation at secondary care level revealed hypercalcemia (18.3 mg/dl) with high intact ...

ea0029p228 | Calcium & Vitamin D metabolism | ICEECE2012

Vitamin D status in primary hyperparathyroidism: a ‘Southern European’ observational study

Tassone F. , Baffoni C. , Gianotti L. , Pellegrino M. , Cassibba S. , Magro G. , Cesario F. , Borretta G.

Introduction: It has been reported that vitamin D deficiency is common in patients with primary hyperparathyroidism (pHPT), and this could affect the clinical expression of the disease. However only few studies addressed this issue and refer to American or North European patients. In these studies, only about one third of the patients showed a vitamin D replete state.Subjects and methods: In 207 consecutive pHPT patients (M/F=45/162, age (mean ±<sma...

ea0011p193 | Clinical practise and governance | ECE2006

Adequacy of post-glucose gh nadir <1 μg/l to define biochemical and neuroradiological remission of acromegaly

Ronchi CL , Varca V , Giavoli C , Ferrante E , Lania A , Arosio M , Beck-Peccoz P , Spada A

We previously demonstrated that acromegalic patients with normal IGF-I levels after surgery also met the current criteria for cure (i.e. postglucose GH nadir <1 μg/l) after long term monitoring. Since some Authors recently proposed to even lower the present GH nadir cut off value, the aim of this study was to confirm its adequacy to define long lasting disease remission. A group of 24 acromegalic patients (9 M&15 F, age 54.2±9.6 yrs) normal IGF-I levels and p...

ea0032p644 | Male reproduction | ECE2013

Endocrine disruptors target ATP binding cassette transporters in the blood–testis barrier and impair Leydig cell steroidogenesis

Roelofs Maarke J E , Dankers Anita C A , Piersma Aldert H , Russel Frans G M , van den Berg Martin , Masereeuw Rosalinde , van Duursen Majorie B M

Efflux transporters in the blood–testis barrier (BTB) prevent entry and accumulation of xenobiotics in testis but are also involved in local transport of steroid hormones. Among these are the ATP-binding cassette (ABC) transporters, P-glycoprotein (P-gp/ABCB1) and multidrug resistance proteins 1 (MRP1/ABCC1) and 4 (MRP4/ABCC4). Here, we studied the interaction of suggested endocrine disruptors (EDCs) bisphenol A (BPA), tetrabromobisphenol A (TBBPA), bis(...

ea0018p9 | (1) | MES2008

Challenges in the management of Cushing's syndrome in the severely ill patient

Fountain A E C , McGowan B M C , Chaudhuri O , Saha S , Field B C T , Dhillo W , Todd J F , Goldstone A P , Martin N M , Meeran K , Tan T

We present a 57-year-old female with Cushing’s syndrome characterised by new type 2 diabetes, hypertension, weight gain, bruising, proximal myopathy and depression. She also had poorly-healing cellulitic ulcers on both legs. Investigations: hypokalaemia and ACTH-dependent Cushing’s syndrome. Low dose dexamethasone suppression test: T=0 ACTH 85 ng/l, cortisol 907 nmol/l, T=48 h cortisol 807. High dose dexamethasone suppression test failed to suppr...

ea0008p70 | Neuroendocrinology and behaviour | SFE2004

Blood Cerebrospinal Fluid Barrier (BCB) for TSH, Prolactin and Insulin in Pregnancy

Lutescu I , Gussi IL , Banceanu G , Coculescu M

The blood-brain barrier for peptide hormones is protective for the maternal brain.OBJECTIVE: To compare peptide hormone levels on the two sides of the blood cerebrospinal fluid barrier in pregnant, non pregnant and menopausal women.METHODS: We investigated, with the approval of the local ethics committee, 35 healthy pregnant women at term, aged 21-41 years (group G), 27 non-pregnant women aged 21-43 years (group C) and 15 menopausa...

ea0029p1761 | Thyroid cancer | ICEECE2012

Differential proteomics in human normal or papillary thyroid carcinoma cell cultures

Rodrigues J , Garcia-Rendueles M , Garcia-Rendueles A , Perez S , Barreiro F , Cameselle-Teijeiro J , Alvarez C , Bravo S

Up to now there are few studies about differential proteomics in thyroid. Our group has developed a method for standard human primary thyroid culture maintaining the phenotype through passages. Thus, we believe of great interest the search for biomarkers in these cultures by 2D-PAGE coupled to MALDI-TOF/TOF-MS.Aims: i) To standardize the conditions for sample extraction and controls. ii) To compare and identify the differential proteomic pattern between ...